YAFO-HM and GB Partner Launch U.S. East Coast NewCo Innovation Hub to Accelerate Global Biotech Growth
Philadelphia, PA — November 11, 2025 — YAFO Capital, Haomai Technology, and GB Partner today announced the launch of the U.S. East Coast NewCo Innovation Hub, designed to accelerate global biotech and biopharmaceutical growth.
The Hub will support both early-stage and established companies with innovative pipelines, platforms, and services seeking international expansion.
Based in Philadelphia — a central node of the U.S. East Coast biotech corridor — the Hub connects Boston and New York’s scientific innovation with the policy and capital hubs of Washington, D.C.
This strategic position gives companies unmatched access to research, investors, and major market partners within a short reach of every key East Coast innovation center.
YAFO-HM combines global business development advisory with AI-driven analytics and biotech consulting.
GB Partner contributes deep capabilities in NewCo creation, strategic financing, regulatory strategy, and cross-border commercialization.
The U.S. East Coast NewCo Innovation Hub’s mission is to transform promising science into globally competitive enterprises, providing tailored support in business strategy, regulatory planning, investment access, and strategic partnerships.
“Located at the heart of the East Coast biotech corridor, Philadelphia is rapidly becoming a leading hub for biotechnology innovation—particularly in the field of advanced therapies.” said Holly Meng, CEO of GB-Partner. “From this pivotalstrategic position, we connect innovators, investors, and partners—empowering biotech and biopharma companies to reach global markets and realize their full potential.”
“Biotech innovations from Asia now account for nearly 50% of global BD transactions, driven by strengths in early discovery, clinical execution, and development efficiency,” said Sean Jiang, Founder and CEO of YAFO.“We aim to help more innovators leverage these advantages to accelerate their global pipelines.”
The U.S. East Coast NewCo Innovation Hub will host its first activities at the YAFO ACCESS ASIA BD Forum on January 11, 2026, during JPM Week in San Francisco.
The forum will showcase NewCo-focused panels, company presentations, and 1×1 partnering meetings.
Scan the qrcode to register
Founded in 2013, YAFO Capital is a global boutique investment and BD advisory firm with professional teams across China, the U.S., Europe, and Southeast Asia. Its four core business segments include transaction advisory and consulting, NewCo incubation, investment fund management, and partnering forums (ACCESS ASIA BD Forum). YAFO has built a strong track record, closing dozens of business development transactions with leading global pharmaceutical and biotech companies.
Founded in Philadelphia, GB Partner is a U.S.-based company built by visionary leaders with a passion for global collaboration and innovation. With access to a network of over 1,000 experts and partnerships with more than 100 leading institutions worldwide, GB Partner offers strategic support to life sciences and healthcare companies expanding across borders—helping them unlock new markets, navigate complex challenges, and drive transformative growth.
Haomai Technology is a consulting organization specializing in biotechnology and artificial intelligence–based big data analytics.
With over a decade of experience, Haomai brings together an interdisciplinary team spanning bioinformatics, computational chemistry, immunology, and pharmacology. The company provides cutting-edge services in drug discovery, project evaluation, and BD transactions.
